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Actinic prurigo (AP) is a type of photodermatosis that primarily affects the Latin American mestizo population. Histologically, 
AP cheilitis exhibits acanthosis with spongiosis and vacuolation of the basal cell layer overlying a dense lymphocytic 
inflammatory infiltrate that forms well-defined lymphoid follicles. Toluidine blue is a thiazide, acidophilic, and metachromatic 
dye used in vivo to selectively stain the acidic components of tissues such as sulfates, carboxylates, and phosphate radicals 
that are incorporated into DNA and RNA. It is necessary to develop a method that allows detecting, on clinical grounds 
the area of the lesion in which it is more feasible to find such structures. Thus to increase the sensitivity of the biopsy, in 
AP cheilitis to accurately identify where the lymphoid follicles reside, based on the higher concentration of DNA in such 
structures and thus confirm the diagnosis. In this study, staining was positive in 85% of patients with AP cheilitis, in 14 
of whom 82% lymphoid follicles were observed by histopathology. One of the pathologist’s problems in establishing 
the diagnosis of AP is that the main histopathological characteristics are not always identified in the submitted samples 
because it is not easy to clinically identify the most representative site of the lesion selected for performing a biopsy. 
Based on our results, we propose using toluidine blue as an auxiliary method to choose a tissue sample to facilitate the 
diagnosis and allow clinicians to make clinical correlations between the histopathological and therapeutic findings. 
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Actinic prurigo (AP) is a type of photodermatosis 
that primarily affects the Latin American mestizo 
population. AP is related to genetic susceptibility, 
specifically in the HLA-DR4 allele, which varies between 
populations.1
The skin lesions in AP are polymorphic and 
include erythematous macules, papules that converge 
and form plaques, serohematic crusts, lichenification 
areas, scarring and hypopigmentation or residual 
hyperpigmentation. Further, lower lip involvement at 
the vermillion border is common in a high percentage 
of the affected individuals and maybe the only 
expression of the disease, when is commonly termed 
as AP cheilitis; in this location, it is characterized by 
edema, cracks, fissures, ulcers that are covered by 
serohematic crusts, erythema and areas of residual 
hyperpigmentation. that is associated with intense 
pruritus that extends to the adjacent skin.1
Value of the toluidine blue test as an aid to determine the biopsy site in actinic prurigo cheilitis
2-4 Autops Case Rep (São Paulo). 2021;11:e2021247
Histologically, AP cheilitis exhibits acanthosis 
with spongiosis and vacuolation of the basal cell layer 
overlying a dense lymphocytic inflammatory infiltrate 
that forms well-defined lymphoid follicles (comprising 
B lymphocytes in the center and T lymphocytes at the 
periphery), macrophages, eosinophils, and mast cells 
(Figure 1).2
AP cheilitis affects 85% of patients and is the 
sole manifestation of the disease in 27% of those 
who are affected.2 Diagnosis of AP when there is 
only lip involvement requires an assessment of its 
clinical and histopathological characteristics, and very 
often, it is necessary to take several tissue samples to 
demonstrate the presence of lymphoid follicles, which 
are considered an essential element to confirm the 
nature of this disorder.
Toluidine blue is a thiazide, acidophilic, and 
metachromatic dye used in vivo, to selectively 
stain the acidic components of tissues such as 
sulfates, carboxylates, and phosphate radicals that 
are incorporated into DNA and RNA.3,4 Therefore, as 
epithelial dysplasia and carcinomas contain higher 
amounts of DNA and RNA than adjacent normal 
epithelium. Toluidine blue has been used as an 
ancillary method for identifying areas with increased 
cell proliferation in lesions for which there is a clinical 
suspicion of malignancy.5
As only 63.8% of biopsies of AP cheilitis have 
lymphoid follicles,2 it is necessary to develop a method 
that allows detecting, on clinical grounds, the lesion 
area. It is more feasible to find such structures, to 
increase the sensitivity of the biopsy. Consequently, 
we sought to determine the value of toluidine blue 
as an ancillary method in obtaining tissue samples in 
AP cheilitis to accurately identify where the lymphoid 
follicles reside, based on the higher DNA concentration 
in such structures and thus confirm the diagnosis.
We included 20 patients (11 women and 9 men) 
aged between 7 and 45 years (mean 25.7) who 
presented clinically with AP cheilitis (Figure 2A). The 
detection technique comprised the application of 
toluidine blue with a swab along the affected vermillion 
border. After 60 seconds, the site was cleaned with 
2% acetic acid solution and rinsed with water or saline 
Figure 1. Histopathological features of actinic prurigo 
cheilitis.
Figure 2. A – Clinical aspects of actinic prurigo cheilitis; B – Persistent staining with toluidine blue after removing 
dye with 2% acetic acid (positive zone).
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solution, leaving clearly defined an area in which the 
dye persisted visible in the tissue (Figure 2B).
This region was then injected with 0.5 cc of 
2% xylocaine solution with epinephrine, distal to 
the area where the incisional biopsy was performed, 
which included a spindle-shaped fragment of tissue 
of approximately 5 mm in length, fixed in 10% 
formaldehyde, and processed for hematoxylin and 
eosin staining.
DISCUSSION
Toluidine blue is already used to identify malignant/
premalignant lesions in the oral mucosa; although no 
risk of malignant transformation has been reported 
in actinic prurigo cheilitis, it can be considered as an 
aid to decide the site to take the biopsy due to the 
dense lymphocytic inflammatory infiltrate that forms 
well-defined lymphoid follicles pick up the dye.6 In this 
study, staining was positive in 17/20 (85%) patients 
with AP cheilitis, in 14 of whom (82%) lymphoid 
follicles were observed by histopathology. In the 
3 cases in which there were no lymphoid follicles, the 
inflammatory infiltrate was mild to moderate, while in 
the remaining 3 cases that were negative for toluidine 
blue, no inflammatory cells were seen. These findings 
contrast with what has been reported in previous 
studies in which lymphoid follicles were noted in 
only 63.8% of samples,2 submitted to biopsy without 
application of toluidine blue, indicating the greater 
sensitivity of this technique to confirm the diagnosis.
One of the pathologist’s problems to establish 
the diagnosis of PA is that the main histopathological 
characteristics are not always identified in the 
submitted samples because it is not easy to clinically 
identify the most representative site of the lesion 
selected for performing a biopsy.
CONCLUSION
Based on our results, we propose using toluidine 
blue as an auxiliary method to choose a tissue sample 
to facilitate the diagnosis and allow clinicians to make 
clinical correlations between the histopathological and 
therapeutic findings.
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